Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease.

Literature DB >> 36170252

Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease.

Shruti Chaturvedi¹, Michael R DeBaun^2,3.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2022 PMID： 36170252 PMCID： PMC9546592 DOI： 10.1073/pnas.2213079119

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 12.779

Keyword Cloud
References

× No keyword cloud information.

16 in total

1. ADAMTS13 activity in sickle cell disease.

Authors: John-John B Schnog; Johanna A Kremer Hovinga; Soraya Krieg; Sakir Akin; Bernhard Lämmle; Dees P M Brandjes; Melvin R Mac Gillavry; Fred D Muskiet; Ashley J Duits
Journal: Am J Hematol Date: 2006-07 Impact factor: 10.047

2. Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia.

Authors: Salah Aref; Hosam Goda
Journal: Hematology Date: 2013-02-20 Impact factor: 2.269

Review 3. Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain.

Authors: Robert P Hebbel
Journal: Hematol Oncol Clin North Am Date: 2014-04 Impact factor: 3.722

4. Evidence of protective effects of recombinant ADAMTS13* in humanized model for sickle cell disease.

Authors: Paolo Rossato; Enrica Federti; Alessandro Matte; Helmut Glantschnig; Fabio Canneva; Maria Schuster; Sogue Coulibaly; Gerald Schrenk; Dirk Voelkel; Michael Dockal; Barbara Plaimauer; Immacolata Andolfo; Achille Iolascon; Hanspeter Rottensteiner; Herbert Gritsch; Friedrich Scheiflinger; Werner Hoellriegl; Lucia De Franceschi
Journal: Haematologica Date: 2022-04-21 Impact factor: 9.941

5. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease.

Authors: Huiping Shi; Bojing Shao; Liang Gao; Thamizhiniyan Venkatesan; John Michael McDaniel; Meixiang Zhou; Samuel McGee; Pengchun Yu; Jasimuddin Ahamed; Janna Journeycake; James N George; Lijun Xia
Journal: Proc Natl Acad Sci U S A Date: 2022-08-15 Impact factor: 12.779

6. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.

Authors: Masayuki Fujioka; Kazuhide Hayakawa; Kenichi Mishima; Ai Kunizawa; Keiichi Irie; Sei Higuchi; Takafumi Nakano; Carl Muroi; Hidetada Fukushima; Mitsuhiko Sugimoto; Fumiaki Banno; Koichi Kokame; Toshiyuki Miyata; Michihiro Fujiwara; Kazuo Okuchi; Kenji Nishio
Journal: Blood Date: 2009-11-13 Impact factor: 22.113

7. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.

Authors: Simon F De Meyer; Alexander S Savchenko; Michael S Haas; Daphne Schatzberg; Michael C Carroll; Alexandra Schiviz; Barbara Dietrich; Hanspeter Rottensteiner; Friedrich Scheiflinger; Denisa D Wagner
Journal: Blood Date: 2012-08-22 Impact factor: 22.113